Alerts will be sent to your verified email
Verify EmailVEERHEALTH
|
Veerhealth Care
|
Samrat Pharmachem
|
Zenith Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.69 % | 18.86 % | 19.81 % |
|
5yr average Equity Multiplier
|
1.35 | 1.83 | 3.92 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 2.61 | 1.08 |
|
5yr Avg Net Profit Margin
|
3.95 % | 3.87 % | 5.08 % |
|
Price to Book
|
3.58 | 1.19 | 0.0 |
|
P/E
|
150.7 | 0.0 | 21.14 |
|
5yr Avg Cash Conversion Cycle
|
43.62 Days | 58.79 Days | -5.9 Days |
|
Inventory Days
|
56.8 Days | 28.98 Days | 59.46 Days |
|
Days Receivable
|
78.02 Days | 80.32 Days | 153.74 Days |
|
Days Payable
|
63.05 Days | 46.76 Days | 283.33 Days |
|
5yr Average Interest Coverage Ratio
|
208.02 | 16.47 | 3.87 |
|
5yr Avg ROCE
|
3.74 % | 27.43 % | 26.61 % |
|
5yr Avg Operating Profit Margin
|
0.37 % | 5.58 % | 9.63 % |
|
5 yr average Debt to Equity
|
0.07 | 0.21 | 1.03 |
|
5yr CAGR Net Profit
|
0.52 % | 5.93 % | 17.92 % |
|
5yr Average Return on Assets
|
2.06 % | 10.3 % | 5.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.5 % | 49.09 % | 69.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.74 % | 0.45 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Veerhealth Care
|
Samrat Pharmachem
|
Zenith Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|